Coalesce Capital Acquires Leading Healthcare IT and Business Solutions Provider DAS Health

NEW YORK and TAMPA, Fla., May 27, 2025 /PRNewswire/ -- Coalesce Capital ("Coalesce"), a private equity firm focused on investing in human capital-driven and technology-enabled services companies, today announced it has acquired a majority stake in DAS Health Ventures ("DAS Health"), a leading provider of healthcare IT and business solutions. Sheridan Capital Partners ("Sheridan"), which invested in DAS Health in 2021, will retain a minority ownership position and continue to support the company's growth.

DAS Health provides a comprehensive suite of IT, cybersecurity, revenue cycle management, and business solutions to thousands of healthcare organizations across North America, streamlining workflows, increasing productivity, and improving patient care. Coalesce will support DAS Health's growth by investing in technology, talent, and strategic acquisitions, further strengthening the company's ability to deliver value to healthcare organizations.

"We are thrilled to welcome Coalesce Capital as we embark on this next chapter for DAS Health," said Michelle Jaeger, President & CEO of DAS Health. "Their investment underscores our commitment to delivering innovative solutions that help healthcare organizations operate more efficiently and improve patient care. With Sheridan's continued support, we are well-positioned to broaden our reach and help even more providers achieve operational excellence and better outcomes."

"As healthcare organizations face growing challenges in patient data management, regulatory compliance, and operational demands, DAS Health stands out as a trusted partner solving these critical pain points," said Stephanie Geveda, Founder & Managing Partner at Coalesce Capital. "We are excited to invest in DAS Health, whose proven track record for delivering reliable, mission-critical solutions has already improved care for over 15 million patients. We look forward to supporting their continued growth."

"DAS Health's achievements reflect the dedication of Sheridan and the entire DAS Health team, who have built a platform that addresses the most urgent needs of healthcare providers," added Austin Heiman, Managing Director at Coalesce Capital. "We are excited to partner with Sheridan and the team to broaden their solutions and continue to help providers navigate the increasingly complex healthcare technology landscape."

"Since partnering with DAS Health in 2021, we have seen the company significantly expand its solutions and deliver increasing value to a growing client base," said Jonathan Lewis, Partner at Sheridan. "We are proud of the DAS Health team's progress and look forward to supporting their continued expansion alongside Coalesce to deliver even more impact for healthcare organizations." 

Houlihan Lokey served as financial advisor and McDermott Will & Emery LLP served as legal advisor to DAS Health and its shareholders. Lazard served as financial advisor and Latham & Watkins, LLP served as legal advisor to Coalesce Capital. Financial terms of the transaction were not disclosed.

About DAS Health 
DAS Health is a leading provider of healthcare IT and business solutions to independent and enterprise physician groups and healthcare systems across North America. Headquartered in Tampa, FL with regional offices in 15 US states and Canada, and an employee presence in 6 Canadian provinces and over 35 US states, DAS delivers managed IT services, cybersecurity, cloud hosting, revenue cycle management, value-based care, patient engagement, compliance, and practice management solutions impacting over 15 million patients nationwide. For more information, please visit www.dashealth.com.

About Coalesce Capital 
Coalesce Capital is a private equity firm that partners with entrepreneurs and management teams to build enduring value around differentiated businesses. Coalesce has over $1.4 billion of regulatory assets under management and is dedicated to investing in human capital-driven and technology-enabled services companies. The firm's growth-oriented investment philosophy centers around its conviction that people are the most important ingredient of value creation. Coalesce leverages its sector expertise, strategic resources and capital to collaborate with management teams to create shared success. For more information, please visit www.coalescecap.com. Follow Coalesce on LinkedIn: @Coalesce.

About Sheridan Capital Partners
Sheridan Capital Partners is a Chicago-based healthcare private equity firm that focuses on lower middle market buyouts and growth equity in the U.S. and Canada. Sheridan partners with companies in the verticals of providers and provider services, healthcare IT and outsourced services, and consumer health and medical products, and strives to bring strategic resources to accelerate growth, build enduring value, and achieve strong results. For more information, please visit www.sheridancp.com.

Media Contact
Ed Trissel / Sarah Salky / Kate Thompson
Joele Frank, Wilkinson Brimmer Katcher
212-355-4449
[email protected]

SOURCE Coalesce Capital